Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues

Javed Butler*, Milton Packer, Stephen J. Greene, Mona Fiuzat, Stefan D. Anker, Kevin J. Anstrom, Peter E. Carson, Lauren B. Cooper, Gregg C. Fonarow, Adrian F. Hernandez, James L. Januzzi, Mariell Jessup, Rita R. Kalyani, Sanjay Kaul, Mikhail Kosiborod, Jo Ann Lindenfeld, Darren K. McGuire, Marc S. Sabatine, Scott D. Solomon, John R. TeerlinkMuthiah Vaduganathan, Clyde W. Yancy, Norman Stockbridge, Christopher M. O'Connor

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues'. Together they form a unique fingerprint.

Medicine & Life Sciences